KCM
KIN

Kathmere Capital Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Kathmere Capital Management’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,348
Closed -$6K – 431
2020
Q4 		$6K Hold
1,348
– – ﹤0.01% 342
2020
Q3 		$6K Buy
+1,348
New +$6K ﹤0.01% 323